The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Gezen Ak, Duygu ^a   Dursun, Erdinç ^a   Yilmazer, Selma ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIFEDIOL; CALCITRIOL; CALCIUM CHANNEL L TYPE; MESSENGER RNA; NERVE GROWTH FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VOLTAGE SENSITIVE CALCIUM CHANNEL L TYPE A1C; VOLTAGE SENSITIVE CALCIUM CHANNEL L TYPE A1D; CACNA1C PROTEIN, RAT; CACNA1D PROTEIN, RAT; CALCITRIOL RECEPTOR; CALCIUM CHANNEL;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; GENE REPRESSION; GENE SILENCING; HUMAN; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN SECRETION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SPRAGUE DAWLEY RAT; VITAMIN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; CELL DEATH; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

RATTUS;

ANIMALS; BLOTTING, WESTERN; CALCITRIOL; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CELL DEATH; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; NERVE GROWTH FACTOR; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 79952303913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017553     Document Type: Article

References (38)

1. Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A, (1998) Vitamin D metabolism and action. Osteoporos Int 8: 13-19.
2. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, et al. (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21: 98-108.
3. Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O, (2006) Chronic 1,25-(OH)2vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging. Cell Calcium 40: 277-286.
4. Brown J, Bianco JI, McGrath JJ, Eyles DW, (2003) 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343: 139-143.
5. Cekic M, Sayeed I, Stein DG, (2009) Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrin 30: 158-172.
6. Cornet A, Baudet C, Neveu I, Baron-Van Evercooren A, Brachet P, et al. (1998) 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res 53: 742-746.
7. Dursun E, Gezen-Ak D, Ertan T, Bilgiç B, Gürvit H, et al. (2009) Interleukin-1α-889 C/T Polymorphism in Turkish Patients with Late-Onset Alzheimer's Disease. Dement Geriatr Cogn Disord 27: 82-87.
8. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D, (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13: 100-105.
9. Landfield PW, Cadwallader-Neal L, (1998) Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging 19: 469-477.
10. Luine V, Sonnenberg J, Christakos S, (1987) Vitamin D: is the brain a target? Steroids 49: 133-153.
11. Neveu I, Naveilhan P, Jehan F, Baudet C, Wion D, et al. (1994) 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 24: 70-76.
12. Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, et al. (2001) Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 904: 67-75.
13. Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, et al. (1991) 1,25 dihydroxivitamin-D3 is a potent inducer of NGF synthesis. J Neurosci Res 28: 110-114.
14. Feron F, Burne THJ, Brown J, Smith E, McGrath JJ, et al. (2005) Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65: 141-148.
15. Fleet JC, (2004) Rapid, Membrane-Initiated Actions of 1,25 Dihydroxyvitamin D: What Are They and What Do They Mean? J Nutr 134: 3215-3218.
16. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ, (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29: 21-30.
17. Holick M, (1995) Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 17: 107-111.
18. McCann J, Ames BN, (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22: 982-1001.
19. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, et al. (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74: 27-32.
20. Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RGJ, et al. (2009) VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 30: 466-473.
21. Llewellyn DJ, Langa KM, Lang IA, (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22: 188-195.
22. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, et al. (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170: 1135-1141.
23. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC, (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriat Psychiat 14: 1032-1040.
24. Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, et al. (2007) Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 212: 275-282.
25. Dursun E, Gezen-Ak D, Yilmazer S, (2011) A novel perspective for Alzheimer's disease: vitamin D receptor suppression by Amyloid-β and preventing the Amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 23: 207-219.
26. Khazai N, Judd SE, Tangpricha V, (2008) Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10: 110-117.
27. Larrosa M, Gratacos J, Vaqueiro M, Prat M, Campos F, et al. (2001) Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment. Med Clin (Barc) 117: 611-614.
28. Rozema D, Lewis DL, (2003) siRNA delivery technologies for mammalian systems Targets 2: 253-260.
29. Keisala TMA, Lou YR, Zou J, Kalueff AV, Pyykkö I, et al. (2009) Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 115: 91-97.
30. Yoshizawa THY, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16: 391-396.
31. Yamaguchi M, (2002) Impact of aging on calcium channels and pumps. Adv Cell Aging Gero 10: 47-65.
32. Thibault O, Gant JC, Landfield PW, (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6: 307-317.
33. Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, et al. (2006) Chronic vitamin D(3) treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 83: 1179-1189.
34. Kato S, Sekine K, Matsumoto T, Yoshizawa T, (1998) Molecular genetics of vitamin D receptor acting in bone. J Bone Miner Metab 16: 65-71.
35. Peeraully MR, Jenkins JR, Trayhurn P, (2004) NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. Am J Physiol Endocrinol Metab 287: 331-339.
36. Tuszynski MH, Thal L, Pay M, Salmon DP, Sang U H, et al. (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11: 551-555.
37. Price P, Brewer GJ, (1998) Serum-Free Media for Neural Cell Cultures. In: Fedoroff S, Richardson A, editors. Protocols for Neural Cell Culture. 3 ed New Jersey Humana Press pp. 255-264.
38. Nolan T, Hands BE, Bustin SA, (2006) Quantification of mRNA using real-time RT-PCR. Natureprotocols 1: 1556-1582.